These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 112495)

  • 21. Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment.
    Kumar AJ; Leeds NE; Fuller GN; Van Tassel P; Maor MH; Sawaya RE; Levin VA
    Radiology; 2000 Nov; 217(2):377-84. PubMed ID: 11058631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can standard magnetic resonance imaging reliably distinguish recurrent tumor from radiation necrosis after radiosurgery for brain metastases? A radiographic-pathological study.
    Dequesada IM; Quisling RG; Yachnis A; Friedman WA
    Neurosurgery; 2008 Nov; 63(5):898-903; discussion 904. PubMed ID: 19005380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. (18)F-FDOPA PET for differentiating recurrent or progressive brain metastatic tumors from late or delayed radiation injury after radiation treatment.
    Lizarraga KJ; Allen-Auerbach M; Czernin J; DeSalles AA; Yong WH; Phelps ME; Chen W
    J Nucl Med; 2014 Jan; 55(1):30-6. PubMed ID: 24167081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differentiating radiation effect from tumor progression after stereotactic radiosurgery: T1/T2 matching.
    Kano H; Kondziolka D; Lobato-Polo J; Zorro O; Flickinger JC; Lunsford LD
    Clin Neurosurg; 2010; 57():160-5. PubMed ID: 21280510
    [No Abstract]   [Full Text] [Related]  

  • 25. Hyperammonemia (ornithinemia) presenting as a unilateral cerebral mass lesion.
    Amacher AL; Bolton RJ; Gatfield PD
    Surg Neurol; 1976 Sep; (3):159-62. PubMed ID: 959986
    [No Abstract]   [Full Text] [Related]  

  • 26. Disseminated toxoplasmosis with signs and symptoms of a cerebral lesion.
    Norstrand IF; Fani K; Jimenez FA; Sher JH
    N Y State J Med; 1985 Jan; 85(1):40-1. PubMed ID: 3856125
    [No Abstract]   [Full Text] [Related]  

  • 27. Frontal lobe glioma presenting as meningitis. A case report.
    Mishler AJ
    Rocky Mt Med J; 1969 Aug; 66(8):51-2. PubMed ID: 5803061
    [No Abstract]   [Full Text] [Related]  

  • 28. Neurological toxoplasmosis presenting as a brain tumor. Case report.
    Tognetti F; Galassi E; Gaist G
    J Neurosurg; 1982 May; 56(5):716-21. PubMed ID: 7069486
    [No Abstract]   [Full Text] [Related]  

  • 29. [Delayed cerebral radionecrosis with pseudo-tumoral evolution].
    Bernasconi V; Giovanelli M; Perria C; Wildi E
    Minerva Neurochir; 1967; 11(1):28-41. PubMed ID: 5605886
    [No Abstract]   [Full Text] [Related]  

  • 30. [Mesencephalic hematoma as the presenting form of cerebral lymphoma].
    D'Olhaberriague L; Soler-Singla L; Hernández-Vidal A; Matías-Guiu X
    Rev Clin Esp; 1989 May; 184(8):450-2. PubMed ID: 2781081
    [No Abstract]   [Full Text] [Related]  

  • 31. Enhanced accuracy in differential diagnosis of radiation necrosis by positron emission tomography-magnetic resonance imaging coregistration: technical case report.
    Thiel A; Pietrzyk U; Sturm V; Herholz K; Hövels M; Schröder R
    Neurosurgery; 2000 Jan; 46(1):232-4. PubMed ID: 10626957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application value of apparent diffusion coefficient in differentiation of brain radiation-injuries and glioma recurrence.
    Wang YL; Liu MY; Li JF; Zhang J; Sun L; Feng F; Ma L
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Aug; 34(4):396-400. PubMed ID: 22954125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Differentiation between glioma recurrence and radiation-induced brain injuries using perfusion-weighted magnetic resonance imaging].
    Wang YL; Liu MY; Wang Y; Xiao HF; Sun L; Zhang J; Ma L
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Aug; 35(4):416-21. PubMed ID: 23987489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiation-induced telangiectasia in the brain simulates cryptic vascular malformations at MR imaging.
    Gaensler EH; Dillon WP; Edwards MS; Larson DA; Rosenau W; Wilson CB
    Radiology; 1994 Dec; 193(3):629-36. PubMed ID: 7972799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progress in neuro-oncology: imaging in-phase!
    Cottier JP
    Diagn Interv Imaging; 2014 Oct; 95(10):905. PubMed ID: 25288181
    [No Abstract]   [Full Text] [Related]  

  • 36. Neurosarcoidosis presenting as an intracranial mass.
    Cahill DW; Botero E; Robinson WL
    J Fla Med Assoc; 1986 Jan; 73(1):35-9. PubMed ID: 3950571
    [No Abstract]   [Full Text] [Related]  

  • 37. Differential diagnosis of intracranial lesions by Tc-99 m brain scintigram.
    Takeda K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1970 May; 30(2):124-52. PubMed ID: 5271959
    [No Abstract]   [Full Text] [Related]  

  • 38. Prediction of death in serious brain damage.
    Lindgren S; Petersén I; Zwetnow N
    Acta Chir Scand; 1968; 134(6):405-16. PubMed ID: 5731280
    [No Abstract]   [Full Text] [Related]  

  • 39. Multivoxel proton MRS for differentiation of radiation-induced necrosis and tumor recurrence after gamma knife radiosurgery for brain metastases.
    Chernov MF; Hayashi M; Izawa M; Usukura M; Yoshida S; Ono Y; Muragaki Y; Kubo O; Hori T; Takakura K
    Brain Tumor Pathol; 2006 Apr; 23(1):19-27. PubMed ID: 18095115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinguishing glioma recurrence from treatment effect after radiochemotherapy and immunotherapy.
    Yang I; Huh NG; Smith ZA; Han SJ; Parsa AT
    Neurosurg Clin N Am; 2010 Jan; 21(1):181-6. PubMed ID: 19944976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.